ROYCE & ASSOCIATES LP - CONMED CORP ownership

CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 163 filers reported holding CONMED CORP in Q3 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CONMED CORP
ValueSharesWeighting
Q3 2020$2,360,000
+9.3%
30,0000.0%0.02%
+4.2%
Q2 2020$2,160,000
+25.7%
30,0000.0%0.02%
+4.3%
Q1 2020$1,718,000
-47.0%
30,000
+3.4%
0.02%
-20.7%
Q4 2019$3,243,000
+16.3%
29,0000.0%0.03%
+11.5%
Q3 2019$2,788,000
+12.3%
29,0000.0%0.03%
+18.2%
Q2 2019$2,482,000
+1.2%
29,000
-1.6%
0.02%
+4.8%
Q1 2019$2,452,000
+29.8%
29,475
+0.2%
0.02%
+23.5%
Q4 2018$1,889,000
-2.3%
29,423
+20.5%
0.02%
+30.8%
Q3 2018$1,934,000
+9570.0%
24,410
+8617.9%
0.01%
Q2 2018$20,000
+66.7%
280
+53.0%
0.00%
Q1 2018$12,0000.0%183
-24.4%
0.00%
Q4 2017$12,0000.0%242
+10.0%
0.00%
Q3 2017$12,000
-99.7%
220
-99.7%
0.00%
-100.0%
Q3 2015$3,891,000
-18.1%
81,5000.0%0.02%
+5.0%
Q2 2015$4,749,000
+15.4%
81,5000.0%0.02%
+25.0%
Q1 2015$4,115,000
+11.3%
81,500
-0.9%
0.02%
+23.1%
Q4 2014$3,696,000
+22.1%
82,2000.0%0.01%
+30.0%
Q3 2014$3,028,000
-16.6%
82,2000.0%0.01%
-9.1%
Q2 2014$3,629,000
+1.6%
82,2000.0%0.01%0.0%
Q1 2014$3,572,000
+2.2%
82,2000.0%0.01%
+10.0%
Q4 2013$3,494,000
+25.1%
82,2000.0%0.01%
+25.0%
Q3 2013$2,794,000
+8.8%
82,2000.0%0.01%0.0%
Q2 2013$2,568,00082,2000.01%
Other shareholders
CONMED CORP shareholders Q3 2014
NameSharesValueWeighting ↓
HealthCor Management, L.P. 27,500$2,437,6002.23%
Ranger Investment Management 316,318$28,038,4282.08%
Lighthouse Investment Partners, LLC 142,100$12,595,7441.39%
Lighthouse Investment Partners, LLC 139,200$12,338,6881.36%
EARNEST PARTNERS LLC 2,402,352$212,944,4811.30%
Lighthouse Investment Partners, LLC 108,200$9,590,8481.06%
MOODY ALDRICH PARTNERS LLC 51,885$4,599,0860.93%
MOUNTAIN PACIFIC INVESTMENT ADVISERS INC/ID 125,435$11,118,5580.81%
Champlain Investment Partners, LLC 1,275,910$113,096,6620.72%
EPIQ PARTNERS, LLC 10,463$927,4400.62%
View complete list of CONMED CORP shareholders